Intrinsic Value of S&P & Nasdaq Contact Us

Waters Corporation WAT NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
$290.52
-12.2%
Analyst Price Target
$401.00
+21.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Waters Corporation (WAT) trades at a trailing P/E of 29.0, forward P/E of 23.0. Trailing earnings yield is 3.45%, forward earnings yield 4.35%. PEG 57.95. Graham Number is $102.20.

Criteria proven by this page:

  • VALUE (54/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
  • Forward P/E 23.0 (down from trailing 29.0) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 57.95 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield 3.45% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 4.35% as earnings recover.
  • Analyst consensus target $401.00 (+21.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
~
VALUE
54/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
MOAT
76/100
→ Income
GROWTH
30/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — WAT

Valuation Multiples
P/E (TTM)29.0
Forward P/E23.0
PEG Ratio57.95
Forward PEG0.68
P/B Ratio7.27
P/S Ratio5.88
EV/EBITDA19.0
Per Share Data
EPS (TTM)$10.79
Forward EPS (Est.)$14.39
Book Value / Share$43.01
Revenue / Share$53.16
FCF / Share$9.07
Yields & Fair Value
Earnings Yield3.45%
Forward Earnings Yield4.35%
Dividend Yield0.00%
Graham Number$102.20
SharesGrow IV$290.52 (-12.2%)
Analyst Target$401.00 (+21.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 20.8 1.56 4.72 5.01 -
2017 759.0 -7.90 6.90 6.68 -
2018 24.5 0.01 9.27 6.00 -
2019 26.7 1.96 -73.06 6.57 -
2020 29.5 -7.17 66.18 6.50 -
2021 33.1 0.98 62.42 8.24 -
2022 29.0 5.94 40.73 6.91 -
2023 30.3 -3.84 16.91 6.58 -
2024 34.5 -31.26 12.04 7.44 -
2025 35.2 75.62 8.83 7.14 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $6.41 $2.17B $521.5M 24.1%
2017 $0.25 $2.31B $20.31M 0.9%
2018 $7.65 $2.42B $593.79M 24.5%
2019 $8.69 $2.41B $592.2M 24.6%
2020 $8.36 $2.37B $521.57M 22.1%
2021 $11.17 $2.79B $692.84M 24.9%
2022 $11.73 $2.97B $707.76M 23.8%
2023 $10.84 $2.96B $642.23M 21.7%
2024 $10.71 $2.96B $637.83M 21.6%
2025 $10.76 $3.17B $642.63M 20.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $14.39 $14.34 – $14.42 $6.42B $6.15B – $6.24B 13
2027 $16.30 $15.81 – $17.41 $7.09B $6.86B – $7.25B 12
2028 $18.04 $16.74 – $20.12 $7.5B $7.5B – $7.52B 4
2029 $20.16 $19.64 – $20.48 $8.05B $7.88B – $8.16B 2
2030 $21.30 $20.74 – $21.62 $8.35B $8.18B – $8.46B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message